After looking into a local Medtronic unit for monopolistic activities, Chinese regulators are charging the company 118.5 million yuan ($17.2 million).
French digital health player Voluntis snagged a CE mark and FDA clearance for its management device for Type 2 diabetics who are treated with basal insulin.
Surgical endoscopy specialist Creo Medical Group is set to raise approximately $26 million in an IPO.
Good Start Genetics is tapping Roche to market its genetic carrier screening technology to obstetricians and general practitioners in the U.S.
Invendo Medical has received a CE mark for a single-use colonoscope it pitches as a way to eliminate the risk of cross-contamination between procedures.
Ennovea Medical is cutting down on electrode placement errors in electrocardiogram recordings with a single-use patch for uniform placement, which was shown…
Teleflex has inked a deal to acquire Vascular Solutions for $1 billion, picking up devices for minimally invasive coronary and peripheral vascular procedures.
A Dallas jury commanded Johnson & Johnson to pay up $1 billion to plaintiffs claiming injury from from the company’s metal-on-metal hip implants. This…
Chinese genomics player Novogene has picked up $75 million in Series B financing.
Boston Scientific is plunking down $75 million in cash to acquire Neovasc’s tissue processing technology, which it will integrate into its structural heart…